NDC 0003-0895

SOTYKTU

Deucravacitinib

SOTYKTU is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Deucravacitinib.

Product ID0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e
NDC0003-0895
Product TypeHuman Prescription Drug
Proprietary NameSOTYKTU
Generic NameDeucravacitinib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-09-09
Marketing CategoryNDA /
Application NumberNDA214958
Labeler NameE.R. Squibb & Sons, L.L.C.
Substance NameDEUCRAVACITINIB
Active Ingredient Strength6 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0003-0895-11

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0895-11)
Marketing Start Date2022-09-09
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [SOTYKTU]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SOTYKTU
SOTYKTU
97558218 not registered Live/Pending
Bristol-Myers Squibb Company
2022-08-22
SOTYKTU
SOTYKTU
97287564 not registered Live/Pending
Bristol-Myers Squibb Company
2022-02-28
SOTYKTU
SOTYKTU
90718747 not registered Live/Pending
Bristol-Myers Squibb Company
2021-05-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.